FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366993317> ?p ?o ?g. }

• W4366993317 endingPage "e003029" @default.
• W4366993317 startingPage "e003029" @default.
• W4366993317 abstract "To investigate sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis.Patients who had an inadequate response to methotrexate (MTX) with or without biological disease-modifying antirheumatic drugs were randomly divided into two groups at baseline, and tofacitinib treatment in combination with MTX was administered to both groups. Either MTX or tofacitinib was then withdrawn if patients achieved Clinical Disease Activity Index remission at week 52. The primary outcome was the proportion of patients who sustained clinical remission at week 104.A total of 113 patients participated in this study. Among them, a total of 48 patients achieved remission at week 52. After discontinuation of tofacitinib, only 29.2% (7/24) of patients remained remission, while 50.0% (10/20) of patients, which was numerically higher but not statistically significant, sustained remission after MTX discontinuation. A greater proportion of bio-naïve patients achieved remission at week 52 and sustained low disease activity with tofacitinib discontinuation at week 104. Additionally, the patients who were able to discontinue tofacitinib without flares had lower rheumatoid factor (p=0.04) and lower anti-cyclic citrullinated peptide antibody (p=0.051) before discontinuation of tofacitinib. No severe adverse events were recorded after discontinuation of tofacitinib or MTX. In patients who relapsed after tofacitinib discontinuation, 71.4% achieved remission with resumption of tofacitinib.This study implies that a blanket cessation of tofacitinib may not be suitable for all patients, given that 58% of the participants experienced relapse. However, the withdrawal of tofacitinib is unlikely to result in the acquisition of treatment-resistance." @default.
• W4366993317 created "2023-04-27" @default.
• W4366993317 creator A5006691121 @default.
• W4366993317 creator A5023567975 @default.
• W4366993317 creator A5034591782 @default.
• W4366993317 creator A5039165431 @default.
• W4366993317 creator A5050749299 @default.
• W4366993317 creator A5058629132 @default.
• W4366993317 creator A5068524115 @default.
• W4366993317 creator A5073326633 @default.
• W4366993317 creator A5086172496 @default.
• W4366993317 creator A5086478930 @default.
• W4366993317 creator A5087307078 @default.
• W4366993317 date "2023-04-01" @default.
• W4366993317 modified "2023-10-12" @default.
• W4366993317 title "Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study" @default.
• W4366993317 cites W2005429018 @default.
• W4366993317 cites W2069302785 @default.
• W4366993317 cites W2104669609 @default.
• W4366993317 cites W2113476392 @default.
• W4366993317 cites W2114909821 @default.
• W4366993317 cites W2120393706 @default.
• W4366993317 cites W2128952811 @default.
• W4366993317 cites W2129948300 @default.
• W4366993317 cites W2135436310 @default.
• W4366993317 cites W2151858167 @default.
• W4366993317 cites W2152348310 @default.
• W4366993317 cites W2152553239 @default.
• W4366993317 cites W2168751860 @default.
• W4366993317 cites W2338749006 @default.
• W4366993317 cites W2606544794 @default.
• W4366993317 cites W2735120995 @default.
• W4366993317 cites W2778484302 @default.
• W4366993317 cites W2901433867 @default.
• W4366993317 cites W2937719347 @default.
• W4366993317 cites W3011903216 @default.
• W4366993317 cites W3094882380 @default.
• W4366993317 cites W3126579487 @default.
• W4366993317 cites W4206693500 @default.
• W4366993317 cites W4210396508 @default.
• W4366993317 cites W4210529991 @default.
• W4366993317 cites W4231972505 @default.
• W4366993317 cites W4249063051 @default.
• W4366993317 cites W4295125684 @default.
• W4366993317 cites W4308769923 @default.
• W4366993317 doi "https://doi.org/10.1136/rmdopen-2023-003029" @default.
• W4366993317 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37185309" @default.
• W4366993317 hasPublicationYear "2023" @default.
• W4366993317 type Work @default.
• W4366993317 citedByCount "0" @default.
• W4366993317 crossrefType "journal-article" @default.
• W4366993317 hasAuthorship W4366993317A5006691121 @default.
• W4366993317 hasAuthorship W4366993317A5023567975 @default.
• W4366993317 hasAuthorship W4366993317A5034591782 @default.
• W4366993317 hasAuthorship W4366993317A5039165431 @default.
• W4366993317 hasAuthorship W4366993317A5050749299 @default.
• W4366993317 hasAuthorship W4366993317A5058629132 @default.
• W4366993317 hasAuthorship W4366993317A5068524115 @default.
• W4366993317 hasAuthorship W4366993317A5073326633 @default.
• W4366993317 hasAuthorship W4366993317A5086172496 @default.
• W4366993317 hasAuthorship W4366993317A5086478930 @default.
• W4366993317 hasAuthorship W4366993317A5087307078 @default.
• W4366993317 hasBestOaLocation W43669933171 @default.
• W4366993317 hasConcept C126322002 @default.
• W4366993317 hasConcept C197934379 @default.
• W4366993317 hasConcept C2777575956 @default.
• W4366993317 hasConcept C2778715236 @default.
• W4366993317 hasConcept C2778886723 @default.
• W4366993317 hasConcept C2781059491 @default.
• W4366993317 hasConcept C71924100 @default.
• W4366993317 hasConcept C90924648 @default.
• W4366993317 hasConceptScore W4366993317C126322002 @default.
• W4366993317 hasConceptScore W4366993317C197934379 @default.
• W4366993317 hasConceptScore W4366993317C2777575956 @default.
• W4366993317 hasConceptScore W4366993317C2778715236 @default.
• W4366993317 hasConceptScore W4366993317C2778886723 @default.
• W4366993317 hasConceptScore W4366993317C2781059491 @default.
• W4366993317 hasConceptScore W4366993317C71924100 @default.
• W4366993317 hasConceptScore W4366993317C90924648 @default.
• W4366993317 hasFunder F4320334764 @default.
• W4366993317 hasIssue "2" @default.
• W4366993317 hasLocation W43669933171 @default.
• W4366993317 hasLocation W43669933172 @default.
• W4366993317 hasLocation W43669933173 @default.
• W4366993317 hasOpenAccess W4366993317 @default.
• W4366993317 hasPrimaryLocation W43669933171 @default.
• W4366993317 hasRelatedWork W1984540686 @default.
• W4366993317 hasRelatedWork W1998887580 @default.
• W4366993317 hasRelatedWork W2014330392 @default.
• W4366993317 hasRelatedWork W2136149735 @default.
• W4366993317 hasRelatedWork W2343417581 @default.
• W4366993317 hasRelatedWork W2411407713 @default.
• W4366993317 hasRelatedWork W2469938290 @default.
• W4366993317 hasRelatedWork W2737739855 @default.
• W4366993317 hasRelatedWork W2755978387 @default.
• W4366993317 hasRelatedWork W2916976992 @default.
• W4366993317 hasVolume "9" @default.
• W4366993317 isParatext "false" @default.

• next